Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Guidelines for Drug Donations - Revised 1999
(1999; 24 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoChanges incorporated into the 1999 edition
Ver el documentoI. Introduction
Ver el documentoII. The need for guidelines
Ver el documentoIII. Core principles
Abrir esta carpeta y ver su contenidoIV. Guidelines for drug donations
Abrir esta carpeta y ver su contenidoV. Other ways donors can help
Abrir esta carpeta y ver su contenidoVI. How to implement a policy on drug donations
Ver el documentoAnnex: Examples of problems with drug donations
Ver el documentoAcknowledgements
Ver el documentoReferences
Ver el documentoBack Cover

Back Cover

There are many types of drug donation. Some are a rapid response to an acute emergency or form a component of development aid. Others represent the philanthropic aims of large corporations. Yet others are small and targeted for use by individual health facilities. But all too often, drug donations are inappropriate and cause disposal problems for their recipients.

By describing “good donation practice”, these guidelines aim to improve the quality of drug donations. As a basis for national or institutional guidelines, they can be adapted and implemented by governments and organizations dealing with this type of assistance.

First issued in 1996, the guidelines have since been revised, following an extensive review of experiences with their use. This second edition begins with a discussion of the need for guidelines and goes on to present four core principles and 12 guidelines for drug donations, covering such issues as selection of drugs, quality assurance, and presentation and packaging. Exceptions to the general guidelines are also given, to take account of specific drug donation situations.

The guidelines conclude with suggestions on other ways in which donors can provide assistance, and advice on how recipients can implement a drug donations policy.

This is an intergagency consensus document published by the WHO Department of Essential Drugs and Other Medicines on behalf of the organizations listed.

Ir a la sección anterior
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 6 diciembre 2017